Xenon Pharmaceuticals Inc (XENE)

Investing Cash Flow

-$331.24M

Quarterly · Period ending: · USD

XENE logo

XENE Investing Cash Flow

Latest reported-$331.24M
XENE Quarterly Cash from Investing (-$209.50K → -$331.24M)
High-resolution chart · PNG

XENE investing cash flow history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Xenon Pharmaceuticals Inc Investing Cash Flow — Quarterly (USD)
Period endingInvesting Cash Flow (USD)
-331,238,000
-407,282,000
62,697,000
38,531,000
82,260,000
34,510,000
98,503,000
498,000
110,719,000
-43,193,000
-239,726,000
48,032,000
27,902,000
46,622,000
-14,335,000
-234,097,000
1,317,000
-48,888,000
-215,433,000
15,575,000
8,192,000
-55,104,000
43,199,000
-19,454,401
11,546,154
-52,925,000
-60,266,000
7,749,000
-6,742,000
-7,032,000
-12,556,000
-23,348,000
1,940,000
4,977,000
5,803,000
-89,000
9,333,000
9,247,000
-32,226,000
-111,000
-15,422,000
-83,000
-143,000
8,709,000
137,000
1,491,000
1,040,000
-5,409,000
1,463,000
-338,000
-1,854,000
-9,550,000
-34,000
-34,000
-209,500
-209,500
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.